ACP to hold two Virtual Live Board Review courses
ACP is hosting two Virtual Live courses for Internal Medicine Board Review on May 24-28 and July 12-16. These courses are taught by a faculty of expert clinician educators, and the content is meticulously mapped to the American Board of Internal Medicine exam blueprint. During the course, learners can compare their answers to their peers' in real time and ask questions of the faculty. To help prepare for exam day, attendees will also have unrestricted access to recorded sessions of the course for up to six months after the course concludes. More information and registration are available online.
ACP launches new pain management learning hub
ACP's new Pain Management Learning Hub features resources to help health care professionals better assess and manage patients' pain.
The new peer-to-peer learning materials consist of seven core evidence-based, patient-centered modules and two sets of case studies that provide opportunities to practice pain assessment, diagnostic differentials, multimodality treatment plans, and patient-centered communication. Up to 23 hours of CME/MOC credit are available.
The series is free to ACP members and available for purchase for nonmembers. An ongoing series of recorded videos provides additional information on various aspects of pain management for specific pain conditions. It is free to members and $25 for nonmembers. The hub can be accessed online or through ACP's Online Learning Center.
ACP's Pain Management Learning Hub was funded by an independent educational grant from Pfizer, Inc., in partnership with Lilly USA, LLC.
New video series focuses on adult immunization
A new ACP video series provides a comprehensive review of the 2021 Advisory Committee on Immunization Practices' adult immunization recommendations, including new information on COVID-19 vaccines. In addition to ACIP Adult Immunization Schedule: What's New for 2021, the complete series includes:
- Adult Immunization Recommendations: Focus on Racial and Ethnic Disparities
- Immunization Is for Subspecialists, Too!
- Telehealth to Support Immunization
- Flu versus COVID-19: A Contagious Conundrum
- Influenza Immunization Recommendations Update
- mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna)
- Janssen Vaccine: A Third Vaccine in Our Fight Against COVID-19
The videos were developed through ACP's I Raise the Rates and ACP Advance: COVID-19 Recovery programs supported by the CDC, Merck & Co, Inc., and Pfizer Inc. They and other resources from ACP are available online.
ACP, Annals of Internal Medicine hold fourth virtual forum on COVID-19 vaccines
ACP's and Annals of Internal Medicine's fourth virtual COVID-19 vaccine forum on March 24 covered practical clinical considerations related to the COVID-19 vaccine, including the impact of COVID-19 variants on vaccine efficacy, comparative effectiveness of the different vaccines, and postvaccine behavior recommendations.
The expert panelists included Carlos del Rio, MD, FACP, executive associate dean and distinguished professor in the division of infectious diseases at Emory University School of Medicine in Atlanta; Paul Sax, MD, clinical director in infectious disease and professor of medicine at Harvard Medical School in Boston; and Deborah Cotton, MD, MPH, FACP, deputy editor of Annals of Internal Medicine, who also served as moderator for the discussion.
The full recording is available for replay and is published in Annals of Internal Medicine along with an accompanying commentary.
ICYMI: Highlights from ACP Internist Weekly
- ACP Best Practice Advice supports short courses of antibiotics for several common infections. The guidance addresses chronic obstructive pulmonary disease exacerbation and acute uncomplicated bronchitis, community-acquired pneumonia, uncomplicated urinary tract infection, and cellulitis. It was published April 6 by Annals of Internal Medicine and summarized in the April 6 ACP Internist Weekly.
- U.S. Preventive Services Task Force recommends lung cancer screening for broader patient population. Annual low-dose computed tomography screening is now recommended for adults ages 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. The recommendation was published March 9 by JAMA and summarized in the March 16 ACP Internist Weekly.